4.6 Review

SIRT3 regulates progression and development of diseases of aging

期刊

TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 26, 期 9, 页码 486-492

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2015.06.001

关键词

mitochondria; sirtuins; SIRT3; aging; disease

资金

  1. American Heart Association [12SDG8840004, 12IRG9010008]
  2. Friedreich's Ataxia Research Alliance
  3. Ellison Medical Foundation
  4. National Institutes of Health (NIH) [R01AA022146, R01AG045351, R24DK085610-05]
  5. Duke Pepper Older Americans Independence Center (OAIC) Program in Aging Research - National Institute of Aging [P30AG028716-01]
  6. NIH [5T32-CA059365]
  7. NIH/NIGMS [5T32GM007105-40]

向作者/读者索取更多资源

The mitochondrial sirtuin SIRT3 is a protein deacylase that influences almost every major aspect of mitochondrial biology, including nutrient oxidation, ATP generation, reactive oxygen species (ROS) detoxification, mitochondrial dynamics, and the mitochondrial unfolded protein response (UPR). Interestingly, mice lacking SIRT3 (SIRT3K0), either spontaneously or when crossed with mouse models of disease, develop several diseases of aging at an accelerated pace, such as cancer, metabolic syndrome, cardiovascular disease, and neurodegenerative diseases, and, thus, might be a valuable model of accelerated aging. In this review, we discuss functions of SIRT3 in pathways involved in diseases of aging and how the lack of SIRT3 might accelerate the aging process. We also suggest that further studies on SIRT3 will help uncover important new pathways driving the aging process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据